Latest News about XBI
Recent news which mentions XBI
ETF flows point to ‘skittish’ investors as it’s ‘a little unwieldy out there’ after Fed rate hikes
May 04, 2023
From MarketWatch
A volatile summer is coming as Fed pause, debt tussle meet. Shelter in these stocks, says strategist
May 01, 2023
From MarketWatch
Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names
April 20, 2023
From Benzinga
Biotech ETFs’ Performance Deserves A Look
April 19, 2023
From ETF Trends
Thermo Fisher, Principal Financial Group, And Two Promising ETFs Steal The Show On CNBC's 'Final Trades'
April 14, 2023
From Benzinga
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
April 13, 2023
From Benzinga
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
April 13, 2023
From Benzinga
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
April 12, 2023
From Benzinga
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
April 11, 2023
From Benzinga
Time to Spring-Clean...Your Stock Portfolio
April 10, 2023
From Motley Fool
From Benzinga
From MarketWatch
From Motley Fool
The 3 Best Growth Stocks to Buy in the Biotech Sector
March 29, 2023
From InvestorPlace
Got gold? Biggest gold ETF attracts investors as the ‘safe haven’ yellow metal shines
March 23, 2023
From MarketWatch
US Judge Weighs Nationwide Ban On Abortion Pills
March 16, 2023
From Benzinga
From InvestorPlace
Silicon Valley Bank Meltdown Hits Healthcare Sector As Well
March 13, 2023
From Benzinga
Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs
March 10, 2023
From Benzinga
FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities
March 10, 2023
From Benzinga
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
March 01, 2023
From Benzinga
Stryker, DaVita And These 2 ETFs: CNBC's 'Final Trades'
January 31, 2023
From Benzinga
2 ETFs That Can Set You Up for Life
January 25, 2023
From Motley Fool
Will 2023 be the year that pharma M&A makes a comeback?
January 12, 2023
From MarketWatch
3 Unstoppable ETFs to Stock Up On in 2023
January 09, 2023
From Motley Fool
5 Top Stocks for January
January 01, 2023
From Motley Fool
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
From Benzinga
2 Top Biotech Stocks to Buy for the Long Haul
December 25, 2022
From Motley Fool
Ahead of a year of big unknowns, here are two sectors investors should consider, says this money manager
December 22, 2022
From MarketWatch
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
December 18, 2022
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.